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Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312S250Conclusions: Knees that were replaced (KRs) had lower baseline carti-
lage thickness and greater longitudinal (1 year) cartilage loss than non-
KRs, the differences being strongest in both tibiae. Cartilage loss in the
weight-bearing femur (a region commonly showing the greatest rate and
sensitivity to change), in contrast showed less discrimination. The ability
to discriminate between KRs and non-KRs was greater for “earlier” KRs
(within 2 years after measurement of cartilage loss) than for those who
received KR “later” (year 2-4 after measuring cartilage loss).
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PREDICTORS OF FATIGUE IN PATIENTS WITH HIP AND KNEE
OSTEOARTHRITIS
K.D. Allen y,z, H.B. Bosworth y,z, C.J. Coffman y,z, A.S. Jeffreys y, E.Z.
Oddone y,z, W.S. Yancy, Jr. y,z. yDurham VA Med. Ctr., Durham, NC, USA;
zDuke Univ. Med. Ctr., Durham, NC, USA
Purpose: Fatigue is emerging as an important outcome for patients
with osteoarthritis (OA), but little is known about factors that predict
fatigue severity. This study examined associations of demographic and
clinical factors with fatigue in a cohort of patients with hip and / or knee
OA.
Methods: Participants were n¼291 patients enrolled in a clinical trial of
a combined patient and provider intervention for managing OA at the
Durham Veterans Affairs Medical Center (mean age ¼ 61, SD¼9, 90%
male, 53% non-white - primarily African American). All measures were
from baseline assessments. Fatigue was assessed with a 10cm visual
analog scale (range 0-10) that asked participants to report how much
fatigue has been a problem for them during the past week; anchors
were “Fatigue is no problem” and “Fatigue is a major problem.”
Potential predictors included participant age, race (white vs. non-
white), gender, education (some vs. no college), self-rated health
(excellent, very good, or good vs. fair or poor), pain severity (Western
Ontario and McMasters University Osteoarthritis Index pain subscale),
insomnia (Insomnia Severity Index), and depressive symptoms (Patient
Health Questionnaire-8). Simple linear regression models examined
associations of each individual predictor variable with fatigue, then
a multivariable model was ﬁt including all predictors that were signif-
icantly associated (p<0.01) with fatigue in simple regression models.
Results: The mean fatigue score was 4.8 (SD¼3.1). In simple regression
models, older age was associated with slightly lower fatigue (b¼ - 0.07,
95%CI ¼ -0.1, -0.04; p<0.001), and the following were associate with
more fatigue: fair / poor self-rated health (b¼2.2, 95%CI ¼ 1.3, 3.1;
p<0.001), greater insomnia severity (b ¼ 0.21, 95%CI ¼ 0.2, 0.3,
p<0.001), greater pain severity (b¼ 0.4, 95%CI¼ 0.3, 0.5; p<0.001), and
greater depressive symptoms (b ¼ 0.35, 95%CI ¼ 0.3, 0.4; p<0.001). In
the multivariable model, variables that remained associated with
fatigue were insomnia severity (b ¼ 0.06, 95%CI ¼ 0.01, 0.1; p¼0.0),
pain severity (b ¼ 0.20, 95%CI ¼ 0.1, 0.3; p<0.001), depressive symp-
toms (b ¼ 0.21, 95%CI ¼ 0.1, 0.3; p<0.001).
Conclusions: Fatigue severity was relatively high in this cohort of
patients with OA; mean values on the fatigue visual analog scale were
comparable to those seen in patients with rheumatoid arthritis.
Demographic factors including age, as well as general health, were not
associated with fatigue in the multivariable model. However, key clin-
ical variables related to OA - pain, depressive symptoms, and insomnia -
were associated with more fatigue. These results highlight that fatigue
is part of a cluster of OA-related symptoms that generally worsen with
greater disease severity. Because of its impact on daily activities and
quality of life, fatigue is an important issue to address among patients
with OA.475
MEN WITH EARLY DEGREES OF KNEE OA HAVE ALTERATIONS IN
VOLUNTARY ACTIVITY OF THE VASTUS LATERALIS MUSCLE AND
DECREASES IN ECCENTRIC KNEE EXTENSOR TORQUE
S.M. Mattiello, P.R. Serrão, K. Gramani-Say, F.A. Vasilceac, G.C. Lessi, A.B.
Oliveira. UFSCar, São Carlos - SP, Brazil
Purpose:Weakness of the muscles around the knee joint is common in
individuals with knee OA, especially quadriceps muscle weakness.
Moreover, in these patients the failure of the muscular voluntary
activity has been considered an important contributing factor in
reducing the strength of knee extension. Therefore, investigating these
aspects is essential to directing rehabilitation programs. The aim of thisstudy was to evaluate the knee extensor torque (KET) and electro-
myographic (EMG) activity of subjects with early stages of knee oste-
oarthritis (OA) and to compare with healthy subjects.
Methods: Forty men participated in this study: control group (CG;
n¼18; healthy subjects; 51.86.4 years) and osteoarthritis group (OAG;
n¼22; subjects with grade I or II knee osteoarthritis; 528.1 years). The
assessment of knee extensor torque was performed using an isokinetic
dynamometer (Biodex Multi-Joint System 3, Biodex Medical Inc., NY,
USA). Concentric and eccentric KET were evaluated at angular speeds of
90/s and 180/s simultaneously with electromyographic activity eval-
uation of the Vastus Lateralis (VL) muscle(Root Mean Square value -
RMS). The data were analyzed using Statistica software (version 7,
StatSoft, Inc., Tulsa, USA). For the intergroup analysis, we used the
independent t-test and the Mann-Whitney U test (a<0.05).
Results: Signiﬁcant differences were found between the groups in
eccentric KET at 90/s (p¼0.01) and at 180/s (p¼0.04), and in RMS
during the eccentric contractions, also at both angular velocities
(p<0.01), with higher values for the CG.
Conclusion: Thus, men with grade I or II knee OA have decreased
strength of the eccentric KET and decreased in muscular voluntary
activity, indicating neuromuscular adaptations. The eccentric training of
the knee extensor muscles should be emphasized, beginning in the
early stages of the disease.
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THE EFFECT OF AGE ON THE WOMAC TOTAL WITH CONTINUOUS
VERSUS INTERMITTENT CELECOXIB TREATMENT IN PATIENTS WITH
OSTEOARTHRITIS
M. Noyes Essex, P. Bhadra Brown, G.H. Sands. Pﬁzer Inc, New York, NY,
USA
Purpose: Continuous nonsteroidal anti-inﬂammatory drug (NSAID)
treatment has been shown to be signiﬁcantly more efﬁcacious than
intermittent dosing, over a 22-week period, in preventing subsequent
ﬂares in patients with osteoarthritis (OA) of the knee or hip who
successfully treated an initial ﬂare. We set out to characterize the effect
of age on efﬁcacy, as measured by Western Ontario and McMaster
Universities Osteoarthritis Index (WOMAC) Total score, of continuous
daily celecoxib treatment vs intermittent celecoxib treatment.
Methods: Exploratory analysis of a clinical trial was conducted to
determine if WOMAC Total score during a blinded post-randomization
period differed among patients aged less than 60 or 60 years or more.
858 patients aged 18 to 80 with OA of the knee or hip, meeting Amer-
ican College of Rheumatology criteria, were randomized to receive
celecoxib 200 mg qd either as “continuous” (daily) or “intermittent”
(only when needed to treat OA ﬂare meeting predeﬁned criteria)
treatment. Analyses were performed on the intention-to-treat (ITT)
population ( 1 dose of study medication post-randomization) and
ﬂare-modiﬁed ITT population (all ITT patients with OA ﬂares  14 + 2
days duration), using a 2-sided type I error rate of 0.05.
Results:Mean ages were 51.3 (n ¼ 236) and 67.2 (n ¼ 195) years in the
continuous groups and 51.2 (n ¼ 220) and 66.7 (n ¼ 207) years in the
intermittent groups. For patients aged < 60 years, WOMAC Total least
squares mean (LSM) change from randomization to ﬁnal visit was 1.10
(SD 0.95) in the continuous group and 5.32 (SD 0.98) in the intermittent
group (P < 0.002). LSM change from randomization to ﬁnal visit in
patients aged 60 years was 2.24 (SD 1.06) in the continuous group and
4.60 (SD 1.03) in the intermittent group (P < 0.111). Primary results
showed that while WOMAC Total scores were comparable at random-
ization, LSM increases (worsening) in WOMAC Total during double-
blind treatment were signiﬁcantly less in patients receiving continuous
treatment than those receiving intermittent treatment.
In the ﬂare-modiﬁed ITT population, WOMAC Total LSM change from
randomization to ﬁnal visit in patients aged < 60 years receiving
continuous treatment was -0.05 (SD 1.08) vs 3.66 (SD 1.21) in the
intermittent group (P< 0.023). LSM change from randomization to ﬁnal
visit in the  60 years ﬂare-modiﬁed ITT population was -0.22 (SD 1.26)
vs 2.72 (SD 1.23) in the continuous and intermittent groups, respec-
tively (P ¼ 0.097). WOMAC Total LSM increases were less in the
continuous group than the intermittent group, irrespective of patients’
age, though only signiﬁcantly in those aged < 60 years for both the ITT
and ﬂare-modiﬁed ITT populations. Negative LSM change indicates
improvement in WOMAC Total.
Conclusions: Daily celecoxib treatment was signiﬁcantly more efﬁca-
cious, as assessed by the WOMAC Total score, than intermittent use for
Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312 S251patients aged < 60 years. Patients aged  60 years showed improved
WOMAC Total score for continuous vs intermittent treatment, but
statistical signiﬁcance was not attained. These data may be useful for
health care providers in considering the treatment of OA patients.
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SERUM URIC ACID AS A PREDISPOSING FACTOR OF CLINICO-
RADIOLOGICAL SEVERITY OF OSTEOARTHRITIS KNEE
R.N. Srivastava, D. Sanghi, A. Mishra, A. Sharma, S. Raj, S. Natu. KG Med.
Univ., Lucknow, India
Purpose: Osteoarthritis (OA) is the most common arthritis worldwide.
The association with age, obesity, gender and metabolic factors has
been studied widely. Evidence suggests that hyperuricemia is signiﬁ-
cantly associated with OA of multiple joints. The high level of uric acid
involved in cartilage degeneration may modulate radiological features
of knee OA. Some study reported that uric acid is associated with
generalized OA and other reported that it is a danger signal of increasing
risk for OA through inﬂammasome activation and concluded that
synovial uric acid is a marker of knee OA severity. Both OA and hyper-
uricemia are common in India. This study aimed to investigate the
association of serum uric acid with clinico-radiological feature of knee
OA in Indian population.
Methods: 180 patients of OA knee diagnosed according to American
College of Rheumatology (ACR) guidelines as cases and equal number of
controls were enrolled. Clinical OA outcome: pain, stiffness and func-
tional disability were recorded by knee-speciﬁc WOMAC index and
knee pain was also measured by 10 point VAS. Radiological grading was
done by KL grades. In addition, four individual radiological features
(IRF)- joint space width, osteophyte, subchondral sclerosis and tibio
femoral alignment were also recorded separately. Demographic were
recorded by self report. Serum uric acid levels were measured by
enzymatic method using Uricase - Peroxidase and analyzed for the
interlinking associations.
Results: OA knee cases had signiﬁcant higher BMI than controls in
overall and in both the genders separately. In females, serum uric acid
levels were signiﬁcantly higher in cases in comparison to controls but
such association was not observed in males and in overall subjects.
Other biochemical variable like random blood sugar and total proteins
were not signiﬁcantly different between cases and controls in any
category.
On analyzing serum uric acid level with clinical features, pain (VAS and
WOMAC) was signiﬁcantly associated (p¼0.02 and p¼0.03) with
elevated serum uric acid levels in females; VAS pain alone in overall
study population (p¼0.024) but not in males. While studying the
radiological features, an increase severity of disease (increasing KL
grades) was observed with increase in serum uric acid levels (KL grade 4
was 5.26  1.1, KL grade 3 was 4.32  0 .95 and KL grade 2 was 3.63 
0.95) in overall subjects and in both the genders separately. No signif-
icant association was observed for individual radiological features (IRF).
Conclusion: Radiological severity (KL grade) and knee pain was found
to be signiﬁcantly associated with serum uric acid levels in overall
subjects and in females in OA knee.
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PLASMA ADIPOKINES AS MEDIATORS IN EARLY KNEE
OSTEOARTHRITIS: DATA FROM COHORT HIP AND COHORT KNEE
(CHECK)
W.E. van Spil, P.M. Welsing, M.B. Kinds, S.C. Mastbergen, J.W.
Bijlsma, F.P. Lafeber. Univ. Med. Ctr. Utrecht, Utrecht, The Netherlands
Purpose: Associations of body mass index (BMI) with hand osteoar-
thritis (OA) have suggested that humoral obesity-related factors may be
involved in the pathogenesis of OA. Systemic adipokine levels depend
on BMI (amount of fat), gender (different fat distribution between
genders), and to a lesser extent age. The purpose of the current study
was to determine whether plasma adipokines could be identiﬁed as
potential mediators of associations of BMI and other demographic
variables with radiographic knee parameters in CHECK (Cohort Hip and
Cohort Knee), a cohort of (very) early-stage symptomatic knee and/or
hip osteoarthritis (OA).
Methods: Plasma (p-) leptin, adiponectin, and resistin levels were
determined by enzyme-linked immunosorbent assay. Joint space width
(JSW; minimum, mean medial, and mean lateral), osteophyte (OP) area,and subchondral bone density (BD) were quantiﬁed in detail on post-
eroanterior knee radiographs using Knee Image Digital Analysis (KIDA).
Mediation analysis was performed to determine whether indirect
associations through adipokines could explain (part of the) associations
of BMI and other demographic variables with radiographic knee
parameters.
Results: Adipokine and radiographic data were complete for
approximately 430 CHECK subjects with knee pain. pLeptin was
identiﬁed as potential mediator of associations of BMI and female
gender with JSW. Likewise, pResistin was a potential mediator of an
association of BMI with JSW. None of the adipokines could be
identiﬁed as potential mediators between demographic variables and
OP area. pAdiponectin appeared to be a potential mediator of asso-
ciations of BMI and female gender with subchondral BD. Although
statistically signiﬁcant, associations of demographic variables and
adipokines with radiographic knee parameters were weak and adi-
pokines could explain only part of the associations between demo-
graphic variables and knee parameters.
Conclusions: Systemic adipokines might be mediators of associations
of BMI and gender with JSW and subchondral BD. As such, although
their rolemight be limited, theymay play a role in the etiology of (knee)
OA.479
THE ASSOCIATION BETWEEN KNEE FUNCTION AND RADIOGRAPHIC
OSTEOARTHRITIS IN A POPULATION BASED COHORT - THE
MUSCULOSKELETAL ULLENSAKER STUDY
B. Øiestad y,z, C. Nørstad Engen x, M. Risberg k,y. yNorwegian research
centre for Active Rehabilitation, Oslo, Norway; zOslo Univ. Hosp., Oslo,
Norway; xOslo Sports Trauma Research Ctr., Oslo, Norway; kNorwegian
Sch. of Sport Sci., Oslo, Norway
Purpose: The objective of this study was to investigate the association
between radiographic knee osteoarthritis and knee function evaluated
by both self-reported questionnaires and performance based tests.
Methods: The Musculoskeletal Ullensaker study (MUST) is an ongoing
population-based study of musculoskeletal disorders performed in
Ullensaker municipality representing the Norwegian population. Invi-
tation letters were sent to all the inhabitants between 40 and 79 years
(n¼12000), and those who self-reported either hand, knee, or hip
osteoarthritis, veriﬁed by their general practitioner, were invited to
a clinical examination including functional, clinical, and radiographic
measures of the three joints. Standing radiographs using SynaFlexer
frame for standardized positioning were taken of all the invited
participants and scored with the Kellgren and Lawrence atlas (grade
0-4). Osteoarthritis was deﬁned as KL  grade 2. Knee injury and
Osteoarthritis Outcome Score (KOOS) was used for measuring pain,
symptoms, and activities of daily living (ADL), function in sport and
recreation (sport/rec), and knee-related quality of life (QOL). The
30-second Chair Stand test and 6 min-walk test were included to
measure performance based function. Multivariate regression analyses
with each KOOS subscale and the performance based tests as dependent
variable were associated with radiographic osteoarthritis in one knee,
adjusted for gender, age, and body mass index (BMI).
Results: Three hundred and twenty three patients were examined
between 2010 and 2012 (31% males and 69% females). The mean age
was 63.58.8 years. Knee osteoarthritis was found in 8.7% for the right
knee (n¼28), in 6.8 % for the left knee (n¼22), and 34 patients (10.5%)
had osteoarthritis in both knee joints. Two hundred and twenty seven
patients (70%) had no radiographic knee osteoarthritis. Signiﬁcant
associations were found between radiographic osteoarthritis in one
knee and the following KOOS subscales: pain (BetaSE: -13.73.7,
p<0.000), other symptoms (-13.13.1, p<0.000), ADL (-9.43.5,
p<0.000), sport/rec (-22.75.7, p<0.000) and QOL (-21.44.6,
p<0.000) compared to those without osteoarthritis. No signiﬁcant
associations were found between the 30-second Chair Stand test and 6
min walk test and radiographic osteoarthritis, respectively.
Conclusion: Radiographic knee osteoarthritis was highly signiﬁ-
cantly associated with poorer self-reported knee function compared
to those without radiographic knee osteoarthritis; clinical signiﬁ-
cant differences were disclosed for all KOOS subscales ranging from
9 to 22 points. However, there was no signiﬁcant association
between radiographic knee osteoarthritis and performance based
function.
